ImageVerifierCode 换一换
格式:PDF , 页数:18 ,大小:293.91KB ,
资源ID:820237      下载积分:10000 积分
快捷下载
登录下载
邮箱/手机:
温馨提示:
如需开发票,请勿充值!快捷下载时,用户名和密码都是您填写的邮箱或者手机号,方便查询和重复下载(系统自动生成)。
如填写123,账号就是123,密码也是123。
特别说明:
请自助下载,系统不会自动发送文件的哦; 如果您已付费,想二次下载,请登录后访问:我的下载记录
支付方式: 支付宝扫码支付 微信扫码支付   
注意:如需开发票,请勿充值!
验证码:   换一换

加入VIP,免费下载
 

温馨提示:由于个人手机设置不同,如果发现不能下载,请复制以下地址【http://www.mydoc123.com/d-820237.html】到电脑端继续下载(重复下载不扣费)。

已注册用户请登录:
账号:
密码:
验证码:   换一换
  忘记密码?
三方登录: 微信登录  

下载须知

1: 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。
2: 试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓。
3: 文件的所有权益归上传用户所有。
4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
5. 本站仅提供交流平台,并不能对任何下载内容负责。
6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

版权提示 | 免责声明

本文(KS P 1600-2007 General guideline of safety test for the cell based therapeutic substances《细胞基础治疗的安全性试验一般通用标准》.pdf)为本站会员(eventdump275)主动上传,麦多课文库仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知麦多课文库(发送邮件至master@mydoc123.com或直接QQ联系客服),我们立即给予删除!

KS P 1600-2007 General guideline of safety test for the cell based therapeutic substances《细胞基础治疗的安全性试验一般通用标准》.pdf

1、 KS P 1600KSKSKSKSSKSKSKS KSKSKS SKSKS KSKS SKS KS KS P 1600: 2007(2012 ) 2007 8 31 http:/www.kats.go.krKS P 1600: 2007 : ( ) ( ) () ( ) () ( ) () : (http:/www.standard.go.kr) : :2007 8 31 :2012 12 6 20120679 : : ( 02-509-7294) (http:/www.kats.go.kr). 10 5 , . KS P 1600: 2007 i . iii 1 1 2 1 3 .2 4

2、3 5 3 6 4 6.1 .4 6.2 (cells) .5 6.3 .6 6.4 6 7 .6 7.1 .6 7.2 6 8 .7 8.1 .7 8.2 .7 8.3 7 8.4 .7 9 .7 9.1 , 7 9.2 , 7 10 .8 10.1 .8 10.2 8 10.3 8 10.4 8 11 (risk management) 8 12 .8 12.1 .9 12.2 .9 13 9 KS P 1600: 2007 ii 13.1 .9 13.2 .9 13.3 9 13.4 .9 KS P 1600: 2007 iii . 05 “ ” , . ( ) 4 ( ) 16 2(

3、) (06.10.16, 2006 0543 ) , 06 12 07 6 4 . ( ) 4 ( ) 18 ( ) (07.08.16) (07.08.23, ) (07.08.31, 2007 0592 ) . KS P 1600: 2007 (2012 ) General guideline of safety test for the cell based therapeutic substances 1 . 1 . 2 . , . 2 . . ( ) . KS A 9000_2001, KS P ISO 10993 1, 1: KS P ISO 14630, ISO 10993 7:

4、 1995, Biological evaluation of medical devices Part 7: Ethylene oxide sterilization residuals ISO 11607 1: 2006, Packaging for terminally sterilized medical devices Part 1: Requirements for materials, sterile barrier systems and packaging systems ISO 11607 2: 2006, Packaging for terminally steriliz

5、ed medical devices Part 2: Validation requirements for forming, sealing and assembly processes ISO 13485 : 2003, Medical devices Quality management systems Requirements for regulatory purposes ISO 14155 1: 2003, Clinical investigation of medical devices for human subjects Part 1: General requirement

6、s ISO 14155 2: 2003, Clinical investigation of medical devices for human subjects Part 2: Clinical investigation plans ISO 14971: 2000, Medical devices Application of risk management to medical devices ISO/FDIS 22442 1, Medical devices utilizing animal tissues and their derivatives Part 1: Applicati

7、on of risk management ISO/FDIS 22442 2, Medical devices utilizing animal tissues and their derivatives Part 2: Controls on KS P 1600: 2007 2 sourcing, collection and handling 3 3.1 (cell-based therapeutics) , , , , . , . 3.2 (autogeneic autologous) , , . 3.3 (allogeneic) (species) , , . 3.4 (xenogen

8、eic) , , . 3.5 , , . 3.6 (therapeutic cell) , , , , 3.7 (tissue engineered medical product) , , , . , . 3.8 (artificial tissue structural components) , , , , (scaffold) 3.9 (scaffold) , , , KS P 1600: 2007 3 3.10 (good manufacturing practice) 3.11 (good tissue practice) , . 3.12 (good clinical pract

9、ice) 4 . . , 5 5.1 . a) , , , , , b) c) , , d) (transformation), , e) (6. ), , . (aging) (6. 7. ) f) (6. 7. ) g) , (6. 7. ) KS P 1600: 2007 4 h) i) j) (6. 7. ) k) (13. ) l) , (7. ) m) ( ) (7. ) n) o) , (6. 13. ) (MRI) . p) , , q) r) s) t) u) , . 7. . 5.2 (GTP) , , , (GMP) . 6 6.1 , , , . , , , , . ,

10、 KS P 1600: 2007 5 . 1 . , . a) KS P ISO 10993 1 b) (GCP) ISO 22442 1( ), ISO 22442 2( , ) ISO 22442 3( / TSE ) . . 2 , , (GTP) (GMP) . 3 . 6.2 (cells) 6.2.1 (donner cell selection) . 1 . . . . , (hamydia), (septicaemia) (bacteraemia), (pyasmia), (toxemia) , , , (spongiform encephalopathy) ISO 22442

11、 2 . 2 (GTP) . KS P 1600: 2007 6 6.2.2 (intact cells) ( / / ), ( ), ( , , ) ( , , ) . 6.3 . 1 KS P ISO 10993 1 . 2 . 6.4 (GMP) . 7 7.1 (GMP) , . 1 (GMP) ISO 13485 . . , , 2 (GMP) ISO 13485 , (GTP) . . 7.2 . KS P 1600: 2007 7 . , ISO/TC215 . (GTP) , , . (GMP) . 8 8.1 . , . . ( , , X , , , ) . 8.2 ISO

12、/TC198 . 8.3 KS P ISO 10993 1( ) . ISO 10993 7 . . 8.4 , ISO 22442 3 . 9 9.1 , , ( , , ). , . , . . , . 9.2 , KS P 1600: 2007 8 , , “ ” . 10 10.1 . , . . 10.2 , / . 10.3 . (batch) ( ) . 10.4 , (: “ ” “ ”). . 11 (risk management) . . . , ISO 14971 ISO 22442 1 . 12 KS P 1600: 2007 9 12.1 ISO 10993 . 1

13、2.2 . 13 13.1 , . . ISO 14971 (GCP) , . 13.2 ISO 14971 . a) b) 13.3 , ISO 14155 1 ISO 14155 2 (GCP) . 13.4 . (end point analysis) . 153787 1 145 3(16) (02)26240114 (02)26240148 http:/ KS P 1600: 2007KSKSKS SKSKS KSKS SKS KS SKS KSKS SKSKS KSKSKS General guideline of safety test for the cell based therapeutic substances ICS 11.040.40 Korean Agency for Technology and Standards http:/www.kats.go.kr

copyright@ 2008-2019 麦多课文库(www.mydoc123.com)网站版权所有
备案/许可证编号:苏ICP备17064731号-1